• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状旁腺切除术后继发性甲状旁腺功能亢进的透析患者中不同水平的甲状旁腺激素对全因死亡率的影响

Impact of Different Levels of iPTH on All-Cause Mortality in Dialysis Patients with Secondary Hyperparathyroidism after Parathyroidectomy.

作者信息

Xi Qiu Ping, Xie Xi Sheng, Zhang Ling, Zhang Rui, Xiao Yue Fei, Jin Cheng Gang, Li Yan Bo, Wang Lin, Zhang Xiao Xuan, Du Shu Tong

机构信息

Department of Nephrology, China-Japan Friendship Hospital, Beijing, China.

Department of Nephrology, Nanchong Central Hospital, Second Clinical Medical Institution of North Sichuan Medical College, Nanchong, China.

出版信息

Biomed Res Int. 2017;2017:6934706. doi: 10.1155/2017/6934706. Epub 2017 Jun 5.

DOI:10.1155/2017/6934706
PMID:28656147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5474544/
Abstract

BACKGROUND

Secondary hyperparathyroidism (SHPT) usually required parathyroidectomy (PTX) when drugs treatment is invalid. Analysis was done on the impact of different intact parathyroid hormone (iPTH) after the PTX on all-cause mortality.

METHODS

An open, retrospective, multicenter cohort design was conducted. The sample included 525 dialysis patients with SHPT who had undergone PTX.

RESULTS

404 patients conformed to the standard, with 36 (8.91%) deaths during the 11 years of follow-up. One week postoperatively, different levels of serum iPTH were divided into four groups: A: ≤20 pg/mL; B: 21-150 pg/mL; C: 151-600 pg/mL; and D: >600 pg/mL. All-cause mortality in groups with different iPTH levels appeared as follows: A (8.29%), B (3.54%), C (10.91%), and D (29.03%). The all-cause mortality of B was the lowest, with D the highest. We used group A as reference (hazard ratio (HR) = 1) compared with the other groups, and HRs on groups B, C, and D appeared as 0.57, 1.43, and 3.45, respectively.

CONCLUSION

The all-cause mortality was associated with different levels of iPTH after the PTX. We found that iPTH > 600 pg/mL appeared as a factor which increased the risk of all-cause mortality. When iPTH levels were positively and effectively reducing, the risk of all-cause mortality also decreased. The most appropriate level of postoperative iPTH seemed to be 21-150 pg/mL.

摘要

背景

继发性甲状旁腺功能亢进症(SHPT)在药物治疗无效时通常需要进行甲状旁腺切除术(PTX)。分析PTX后不同的全段甲状旁腺激素(iPTH)水平对全因死亡率的影响。

方法

采用开放、回顾性、多中心队列设计。样本包括525例接受PTX的SHPT透析患者。

结果

404例患者符合标准,在11年的随访期间有36例(8.91%)死亡。术后1周,将不同水平的血清iPTH分为四组:A组:≤20 pg/mL;B组:21 - 150 pg/mL;C组:151 - 600 pg/mL;D组:>600 pg/mL。不同iPTH水平组的全因死亡率如下:A组(8.29%)、B组(3.54%)、C组(10.91%)和D组(29.03%)。B组全因死亡率最低,D组最高。以A组作为参照(风险比(HR)=1),与其他组相比,B组、C组和D组的HR分别为0.57、1.43和3.45。

结论

PTX后全因死亡率与不同的iPTH水平相关。我们发现iPTH>600 pg/mL是增加全因死亡风险的一个因素。当iPTH水平得到积极有效的降低时,全因死亡风险也会降低。术后iPTH的最合适水平似乎为21 - 150 pg/mL。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b36/5474544/6cfcc5f48738/BMRI2017-6934706.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b36/5474544/70f4a14df876/BMRI2017-6934706.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b36/5474544/28707913a568/BMRI2017-6934706.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b36/5474544/6cfcc5f48738/BMRI2017-6934706.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b36/5474544/70f4a14df876/BMRI2017-6934706.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b36/5474544/28707913a568/BMRI2017-6934706.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b36/5474544/6cfcc5f48738/BMRI2017-6934706.003.jpg

相似文献

1
Impact of Different Levels of iPTH on All-Cause Mortality in Dialysis Patients with Secondary Hyperparathyroidism after Parathyroidectomy.甲状旁腺切除术后继发性甲状旁腺功能亢进的透析患者中不同水平的甲状旁腺激素对全因死亡率的影响
Biomed Res Int. 2017;2017:6934706. doi: 10.1155/2017/6934706. Epub 2017 Jun 5.
2
[Total parathyroidectomy in treatment of Sagliker syndrome in 10 cases of hemodialysing patients with secondary hyperparathyroidism].[10例血液透析继发性甲状旁腺功能亢进患者行甲状旁腺全切除术治疗Sagliker综合征]
Zhonghua Nei Ke Za Zhi. 2011 Jul;50(7):562-7.
3
Parathyroidectomy in patients with chronic kidney disease: Impacts of different techniques on the biochemical and clinical evolution of secondary hyperparathyroidism.慢性肾脏病患者甲状旁腺切除术:不同技术对继发性甲状旁腺功能亢进症生化和临床转归的影响。
Surgery. 2018 Feb;163(2):381-387. doi: 10.1016/j.surg.2017.09.005. Epub 2017 Nov 13.
4
Post-parathyroidectomy parathyroid hormone levels: the impact on patient survival - a single-centre study in a stage 5 chronic kidney disease population.甲状旁腺切除术后甲状旁腺激素水平:对患者生存的影响-5 期慢性肾脏病患者的单中心研究。
Nephron Clin Pract. 2011;119(2):c113-20. doi: 10.1159/000326683. Epub 2011 Jul 8.
5
Short- and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients.在血液透析患者中,甲状旁腺全切术并立即自体移植与甲状旁腺次全切除术的短期和长期疗效比较
J Am Soc Nephrol. 1992 Oct;3(4):1008-17. doi: 10.1681/ASN.V341008.
6
Evaluation of laboratory parameters and symptoms after parathyroidectomy in dialysis patients with secondary hyperparathyroidism.评估继发性甲状旁腺功能亢进透析患者甲状旁腺切除术后的实验室参数和症状。
Ren Fail. 2019 Nov;41(1):921-929. doi: 10.1080/0886022X.2019.1666724.
7
Parathyroidectomy decreases serum intact parathyroid hormone and calcium levels and prolongs overall survival in elderly hemodialysis patients with severe secondary hyperparathyroidism.甲状旁腺切除术可降低老年重度继发性甲状旁腺功能亢进血液透析患者的血清完整甲状旁腺激素水平和血钙水平,并延长其总生存期。
J Clin Lab Anal. 2019 Mar;33(3):e22696. doi: 10.1002/jcla.22696. Epub 2018 Nov 28.
8
Effects of Parathyroidectomy on Plasma iPTH and (1-84) PTH Levels in Patients with Stage 5 Chronic Kidney Disease.甲状旁腺切除术对5期慢性肾脏病患者血浆免疫反应性甲状旁腺激素(iPTH)和(1-84)甲状旁腺激素水平的影响
Horm Metab Res. 2018 Oct;50(10):761-767. doi: 10.1055/a-0723-2807. Epub 2018 Sep 17.
9
Survival after parathyroidectomy in chronic hemodialysis patients with severe secondary hyperparathyroidism.重度继发性甲状旁腺功能亢进的慢性血液透析患者甲状旁腺切除术后的生存情况。
Int Urol Nephrol. 2015 Nov;47(11):1871-7. doi: 10.1007/s11255-015-1106-x. Epub 2015 Sep 16.
10
Short- and long-term impact of subtotal parathyroidectomy on the achievement of bone and mineral parameters recommended by clinical practice guidelines in dialysis patients: a 12-year single-center experience.甲状旁腺全切除与次全切除对透析患者骨和矿物质参数达标影响的 12 年单中心经验:短期和长期影响。
Blood Purif. 2013;36(2):116-21. doi: 10.1159/000353415. Epub 2013 Nov 5.

引用本文的文献

1
Efficacy and safety of intermittent intravenous doxercalciferol in the treatment of secondary hyperparathyroidism in Chinese patients on maintenance hemodialysis: a phase II, open-label, prospective, multicenter study.间歇性静脉注射多西骨化醇治疗维持性血液透析中国患者继发性甲状旁腺功能亢进的疗效与安全性:一项II期、开放标签、前瞻性、多中心研究
Front Pharmacol. 2025 Apr 11;16:1574679. doi: 10.3389/fphar.2025.1574679. eCollection 2025.
2
Association between serum intact parathyroid hormone and survival in dialysis patients.透析患者血清完整甲状旁腺激素与生存率之间的关联。
Int Urol Nephrol. 2025 Mar;57(3):1019-1028. doi: 10.1007/s11255-024-04288-y. Epub 2024 Nov 18.
3

本文引用的文献

1
Comparison Between Subtotal Parathyroidectomy and Total Parathyroidectomy with Autotransplantation for Secondary Hyperparathyroidism in Patients with Chronic Renal Failure: A Meta-Analysis.慢性肾衰竭患者继发性甲状旁腺功能亢进行甲状旁腺次全切除术与甲状旁腺全切除术加自体移植术的比较:一项Meta分析
Horm Metab Res. 2015 Aug;47(9):643-51. doi: 10.1055/s-0035-1554689. Epub 2015 Jul 2.
2
Kidney Disease Improving Global Outcomes guidelines and parathyroidectomy for renal hyperparathyroidism.改善全球肾脏病预后组织(KDIGO)指南与肾性甲状旁腺功能亢进的甲状旁腺切除术
J Surg Res. 2015 Nov;199(1):115-20. doi: 10.1016/j.jss.2015.04.046. Epub 2015 Apr 18.
3
Construction and validation of a risk prediction model for early hungry bone syndrome in maintenance hemodialysis patients post-parathyroidectomy.
构建并验证甲状旁腺切除术后维持性血液透析患者早期饥饿骨综合征风险预测模型。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 May 28;49(5):784-794. doi: 10.11817/j.issn.1672-7347.2024.240064.
4
Metabolomic profile of secondary hyperparathyroidism in patients with chronic kidney disease stages 3-5 not receiving dialysis.未接受透析的慢性肾脏病 3-5 期患者继发甲状旁腺功能亢进的代谢组学特征。
Front Endocrinol (Lausanne). 2024 Jul 4;15:1406690. doi: 10.3389/fendo.2024.1406690. eCollection 2024.
5
Effect of total parathyroidectomy in patients with secondary hyperparathyroidism: a retrospective study.甲状旁腺全切除术治疗继发性甲状旁腺功能亢进症的疗效:一项回顾性研究。
Int Urol Nephrol. 2023 May;55(5):1239-1245. doi: 10.1007/s11255-022-03401-3. Epub 2022 Nov 4.
6
Low Parathyroid Hormone Secondary Hyperparathyroidism and Survival in Patients Undergoing Hemodialysis: A Propensity-Matched Analysis.低甲状旁腺激素、继发性甲状旁腺功能亢进症与血液透析患者生存:倾向评分匹配分析。
Front Endocrinol (Lausanne). 2022 May 13;13:869330. doi: 10.3389/fendo.2022.869330. eCollection 2022.
7
Refractory hypercalcemia due to an ectopic mediastinal parathyroid gland in a hemodialysis patient: a case report.血液透析患者异位性纵隔甲状旁腺导致难治性高钙血症:一例报告。
BMC Nephrol. 2019 May 14;20(1):165. doi: 10.1186/s12882-019-1363-5.
Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study.
矿物质和骨代谢标志物的改善与血液透析患者的生存改善相关:COSMOS 研究。
Nephrol Dial Transplant. 2015 Sep;30(9):1542-51. doi: 10.1093/ndt/gfv099. Epub 2015 Apr 28.
4
Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism.甲状旁腺切除术与继发性甲状旁腺功能亢进症的日本血液透析患者的生存。
Kidney Int. 2015 Aug;88(2):350-9. doi: 10.1038/ki.2015.72. Epub 2015 Mar 18.
5
Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.慢性血液透析患者继发性甲状旁腺功能亢进治疗方法的近期变化及其与预后的关系:透析预后与实践模式研究(DOPPS)
Clin J Am Soc Nephrol. 2015 Jan 7;10(1):98-109. doi: 10.2215/CJN.12941213. Epub 2014 Dec 16.
6
Improved long-term survival of dialysis patients after near-total parathyroidectomy.甲状旁腺全切除加前臂移植术后透析患者的长期生存率提高。
J Am Coll Surg. 2012 Apr;214(4):400-7; discussion 407-8. doi: 10.1016/j.jamcollsurg.2011.12.046.
7
Persistently low intact parathyroid hormone levels predict a progression of aortic arch calcification in incident hemodialysis patients.持续性低全段甲状旁腺激素水平可预测新进入血液透析患者的主动脉弓钙化进展。
Clin Exp Nephrol. 2012 Jun;16(3):433-41. doi: 10.1007/s10157-011-0577-z. Epub 2012 Jan 5.
8
Initial parathyroid surgery in 606 patients with renal hyperparathyroidism.606 例肾性甲状旁腺功能亢进症患者的初始甲状旁腺手术。
World J Surg. 2012 Feb;36(2):318-26. doi: 10.1007/s00268-011-1392-0.
9
Diseases of the parathyroid gland in chronic kidney disease.慢性肾脏病中的甲状旁腺疾病。
Clin Exp Nephrol. 2011 Dec;15(6):797-809. doi: 10.1007/s10157-011-0502-5. Epub 2011 Aug 6.
10
Association between very low PTH levels and poor survival rates in haemodialysis patients: results from the French ARNOS cohort.极低甲状旁腺激素水平与血液透析患者生存率降低的关联:来自法国 ARNOS 队列的研究结果。
Nephron Clin Pract. 2011;118(2):c211-6. doi: 10.1159/000321642. Epub 2010 Dec 17.